insights_auto
Why is SOBI up 2.01%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 435.80
arrow_upward
+2.01%(+8.60) 1D
Oct 14, 5:06:31 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 427.40
High
SEKÂ 438.00
Low
SEKÂ 424.80
Mkt. cap
155.86B
Avg. vol.
255.84K
Volume
106.50K
P/E ratio
116.40
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 293.60
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 427.40
High
SEKÂ 438.00
Low
SEKÂ 424.80
Mkt. cap
155.86B
Avg. vol.
255.84K
Volume
106.50K
P/E ratio
116.40
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 293.60
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
ChartMill
·
32 minutes ago
These S&P500 stocks are gapping in today's session
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.26% Higher
The Globe and Mail
·
33 minutes ago
This ETF Has Crushed the S&P 500 in 2026. Here's Why I Think It Still Has Room to Grow.
Yahoo Finance Singapore
·
1 hour ago
The S&P 500 is about to break its longest streak without a 1% drop
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)